Mr Ben Rapinoja > Borenius > Helsinki, Finland > Lawyer Profile

Borenius
ETELÄESPLANADI 2
00130 HELSINKI
Finland

Work Department

Intellectual Property

Position

Partner Ben Rapinoja is a renowned litigator in patent, trademark and intellectual property matters in Finland and an expert in the field of intellectual property, technology law and Market Court proceedings. Ben advises on contractual and licensing arrangements, brands and marketing law related matters, commercial disputes, and corporate transactions in electronics and high-tech industries. His expertise also covers legal issues related to the pharmaceutical industry, health technology and life science sectors. Ben has extensive experience in patent and intellectual property litigation as well as in contractual disputes and arbitration proceedings concerning ICT and high-tech companies.
Ben heads the firm’s Intellectual Property team.

Career

Prior to joining Borenius Attorneys Ltd, Ben has worked at Ministry of Trade and Industry. He has been a partner since 2006.

Languages

Finnish, English, Swedish, French, German

Memberships

Finnish Bar Association, IBA

Education

LL.M. 1993, University of Helsinki, Finland; Trained on the bench 1997, District court of Helsinki, Finland; Admitted to the Bar 2002, Helsinki, Finland

Lawyer Rankings

Finland > Intellectual property

(Leading individuals)

Ben Rapinoja  – Borenius

Borenius is well known for handling disputes, commercial IP work, trade mark portfolio management and regulatory matters related to the food, data, pharmaceuticals and healthcare industries. Jointly leading the team is Ben Rapinoja, who heads up the IP department’s dispute resolution team and focuses on patent and trade mark matters; and Lasse Laaksonen, who steers the firm’s IP and commercial team, specialising in contentious and non-contentious IP and technology law. While Jemina Bonsdorff is well versed in IP litigation and technology and commercial contracts, Wilma Kivilä has extensive experience in the pharmaceuticals, healthcare and life sciences sectors.